BKM120+Abiraterone Acetate for Metastatic CRPC
Clinical trial NCT01741753 · TERMINATED
Trial details
- NCT number
- NCT01741753
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-12-29
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.